#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=2. Follicular Ovarian Reserve and Its Regulation
1-1	0-2	2.	_	_	_	_
1-2	3-13	Follicular	place[2]	new[2]	ana	1-6[0_2]
1-3	14-21	Ovarian	person|place[2]	new|new[2]	coref	2-6
1-4	22-29	Reserve	place[2]	new[2]	_	_
1-5	30-33	and	_	_	_	_
1-6	34-37	Its	place|abstract[4]	giv|new[4]	coref|coref	2-4[7_0]|18-12[155_4]
1-7	38-48	Regulation	abstract[4]	new[4]	_	_

#Text=In mammals , the follicular ovarian reserve , constituted by primordial follicles , is established early on in life then keeps declining regularly throughout the reproductive period .
2-1	49-51	In	_	_	_	_
2-2	52-59	mammals	animal	new	_	_
2-3	60-61	,	_	_	_	_
2-4	62-65	the	place[7]	giv[7]	coref	18-15[156_7]
2-5	66-76	follicular	place[7]	giv[7]	_	_
2-6	77-84	ovarian	person|place[7]	giv|giv[7]	_	_
2-7	85-92	reserve	place[7]	giv[7]	_	_
2-8	93-94	,	place[7]	giv[7]	_	_
2-9	95-106	constituted	place[7]	giv[7]	_	_
2-10	107-109	by	place[7]	giv[7]	_	_
2-11	110-120	primordial	place[7]|animal[8]	giv[7]|new[8]	coref	3-4[12_8]
2-12	121-130	follicles	place[7]|animal[8]	giv[7]|new[8]	_	_
2-13	131-132	,	_	_	_	_
2-14	133-135	is	_	_	_	_
2-15	136-147	established	_	_	_	_
2-16	148-153	early	_	_	_	_
2-17	154-156	on	_	_	_	_
2-18	157-159	in	_	_	_	_
2-19	160-164	life	abstract	new	coref	3-17[17_0]
2-20	165-169	then	_	_	_	_
2-21	170-175	keeps	_	_	_	_
2-22	176-185	declining	_	_	_	_
2-23	186-195	regularly	_	_	_	_
2-24	196-206	throughout	_	_	_	_
2-25	207-210	the	time[10]	new[10]	_	_
2-26	211-223	reproductive	time[10]	new[10]	_	_
2-27	224-230	period	time[10]	new[10]	_	_
2-28	231-232	.	_	_	_	_

#Text=The pool of primordial follicles serves as a source of growing follicles and fertilizable eggs for the entire female reproductive life .
3-1	233-236	The	place[11]	new[11]	coref	19-9[160_11]
3-2	237-241	pool	place[11]	new[11]	_	_
3-3	242-244	of	place[11]	new[11]	_	_
3-4	245-255	primordial	place[11]|animal[12]	new[11]|giv[12]	coref	3-11[14_12]
3-5	256-265	follicles	place[11]|animal[12]	new[11]|giv[12]	_	_
3-6	266-272	serves	_	_	_	_
3-7	273-275	as	_	_	_	_
3-8	276-277	a	abstract[13]	new[13]	_	_
3-9	278-284	source	abstract[13]	new[13]	_	_
3-10	285-287	of	abstract[13]	new[13]	_	_
3-11	288-295	growing	abstract[13]|animal[14]|animal[15]	new[13]|giv[14]|giv[15]	coref|coref	3-11[15_14]|5-6[23_15]
3-12	296-305	follicles	abstract[13]|animal[14]|animal[15]	new[13]|giv[14]|giv[15]	_	_
3-13	306-309	and	abstract[13]|animal[15]	new[13]|giv[15]	_	_
3-14	310-322	fertilizable	abstract[13]|animal[15]|object[16]	new[13]|giv[15]|new[16]	_	_
3-15	323-327	eggs	abstract[13]|animal[15]|object[16]	new[13]|giv[15]|new[16]	_	_
3-16	328-331	for	_	_	_	_
3-17	332-335	the	abstract[17]	giv[17]	coref	8-6[44_17]
3-18	336-342	entire	abstract[17]	giv[17]	_	_
3-19	343-349	female	abstract[17]	giv[17]	_	_
3-20	350-362	reproductive	abstract[17]	giv[17]	_	_
3-21	363-367	life	abstract[17]	giv[17]	_	_
3-22	368-369	.	_	_	_	_

#Text=Actually , each primordial follicle can remain quiescent for years ; be activated and enter the growing process ; or undergo atresia directly from the dormant stage .
4-1	370-378	Actually	_	_	_	_
4-2	379-380	,	_	_	_	_
4-3	381-385	each	object[18]	new[18]	coref	7-23[0_18]
4-4	386-396	primordial	object[18]	new[18]	_	_
4-5	397-405	follicle	object[18]	new[18]	_	_
4-6	406-409	can	_	_	_	_
4-7	410-416	remain	_	_	_	_
4-8	417-426	quiescent	_	_	_	_
4-9	427-430	for	_	_	_	_
4-10	431-436	years	_	_	_	_
4-11	437-438	;	_	_	_	_
4-12	439-441	be	_	_	_	_
4-13	442-451	activated	_	_	_	_
4-14	452-455	and	_	_	_	_
4-15	456-461	enter	_	_	_	_
4-16	462-465	the	abstract[19]	new[19]	coref	18-8[154_19]
4-17	466-473	growing	abstract[19]	new[19]	_	_
4-18	474-481	process	abstract[19]	new[19]	_	_
4-19	482-483	;	_	_	_	_
4-20	484-486	or	_	_	_	_
4-21	487-494	undergo	_	_	_	_
4-22	495-502	atresia	abstract	new	_	_
4-23	503-511	directly	_	_	_	_
4-24	512-516	from	_	_	_	_
4-25	517-520	the	abstract[21]	new[21]	coref	6-2[26_21]
4-26	521-528	dormant	abstract[21]	new[21]	_	_
4-27	529-534	stage	abstract[21]	new[21]	_	_
4-28	535-536	.	_	_	_	_

#Text=To produce mature oocytes , activated primordial follicles develop through primary and secondary stages before acquiring an antral cavity .
5-1	537-539	To	_	_	_	_
5-2	540-547	produce	_	_	_	_
5-3	548-554	mature	plant[22]	new[22]	coref	10-19[0_22]
5-4	555-562	oocytes	plant[22]	new[22]	_	_
5-5	563-564	,	_	_	_	_
5-6	565-574	activated	animal[23]	giv[23]	coref	6-6[27_23]
5-7	575-585	primordial	animal[23]	giv[23]	_	_
5-8	586-595	follicles	animal[23]	giv[23]	_	_
5-9	596-603	develop	_	_	_	_
5-10	604-611	through	_	_	_	_
5-11	612-619	primary	abstract[24]	new[24]	_	_
5-12	620-623	and	abstract[24]	new[24]	_	_
5-13	624-633	secondary	abstract[24]	new[24]	_	_
5-14	634-640	stages	abstract[24]	new[24]	_	_
5-15	641-647	before	_	_	_	_
5-16	648-657	acquiring	_	_	_	_
5-17	658-660	an	place[25]	new[25]	_	_
5-18	661-667	antral	place[25]	new[25]	_	_
5-19	668-674	cavity	place[25]	new[25]	_	_
5-20	675-676	.	_	_	_	_

#Text=At the antral stage , most follicles undergo apoptotic degeneration and only a few of them grow further to reach the preovulatory stage under the cyclic gonadotropin stimulation that occurs after puberty .
6-1	677-679	At	_	_	_	_
6-2	680-683	the	abstract[26]	giv[26]	coref	6-21[30_26]
6-3	684-690	antral	abstract[26]	giv[26]	_	_
6-4	691-696	stage	abstract[26]	giv[26]	_	_
6-5	697-698	,	_	_	_	_
6-6	699-703	most	animal[27]	giv[27]	ana	6-16[0_27]
6-7	704-713	follicles	animal[27]	giv[27]	_	_
6-8	714-721	undergo	_	_	_	_
6-9	722-731	apoptotic	event[28]	new[28]	_	_
6-10	732-744	degeneration	event[28]	new[28]	_	_
6-11	745-748	and	_	_	_	_
6-12	749-753	only	_	_	_	_
6-13	754-755	a	_	_	_	_
6-14	756-759	few	_	_	_	_
6-15	760-762	of	_	_	_	_
6-16	763-767	them	animal	giv	coref	7-15[38_0]
6-17	768-772	grow	_	_	_	_
6-18	773-780	further	_	_	_	_
6-19	781-783	to	_	_	_	_
6-20	784-789	reach	_	_	_	_
6-21	790-793	the	abstract[30]	giv[30]	_	_
6-22	794-806	preovulatory	abstract[30]	giv[30]	_	_
6-23	807-812	stage	abstract[30]	giv[30]	_	_
6-24	813-818	under	_	_	_	_
6-25	819-822	the	event[32]	new[32]	_	_
6-26	823-829	cyclic	event[32]	new[32]	_	_
6-27	830-842	gonadotropin	abstract|event[32]	new|new[32]	_	_
6-28	843-854	stimulation	event[32]	new[32]	_	_
6-29	855-859	that	event[32]	new[32]	_	_
6-30	860-866	occurs	event[32]	new[32]	_	_
6-31	867-872	after	event[32]	new[32]	_	_
6-32	873-880	puberty	event[32]|event	new[32]|new	_	_
6-33	881-882	.	_	_	_	_

#Text=The maintenance of female reproductive function implies the presence of a vast majority of quiescent primordial follicles and continuous repression of primordial follicle activation into early growing follicles .
7-1	883-886	The	abstract[34]	new[34]	_	_
7-2	887-898	maintenance	abstract[34]	new[34]	_	_
7-3	899-901	of	abstract[34]	new[34]	_	_
7-4	902-908	female	abstract[34]|abstract[35]	new[34]|new[35]	_	_
7-5	909-921	reproductive	abstract[34]|abstract[35]	new[34]|new[35]	_	_
7-6	922-930	function	abstract[34]|abstract[35]	new[34]|new[35]	_	_
7-7	931-938	implies	_	_	_	_
7-8	939-942	the	abstract[36]	new[36]	_	_
7-9	943-951	presence	abstract[36]	new[36]	_	_
7-10	952-954	of	abstract[36]	new[36]	_	_
7-11	955-956	a	abstract[36]|person[37]	new[36]|new[37]	_	_
7-12	957-961	vast	abstract[36]|person[37]	new[36]|new[37]	_	_
7-13	962-970	majority	abstract[36]|person[37]	new[36]|new[37]	_	_
7-14	971-973	of	abstract[36]|person[37]	new[36]|new[37]	_	_
7-15	974-983	quiescent	abstract[36]|person[37]|animal[38]	new[36]|new[37]|giv[38]	coref	7-26[42_38]
7-16	984-994	primordial	abstract[36]|person[37]|animal[38]	new[36]|new[37]|giv[38]	_	_
7-17	995-1004	follicles	abstract[36]|person[37]|animal[38]	new[36]|new[37]|giv[38]	_	_
7-18	1005-1008	and	_	_	_	_
7-19	1009-1019	continuous	event[39]	new[39]	_	_
7-20	1020-1030	repression	event[39]	new[39]	_	_
7-21	1031-1033	of	event[39]	new[39]	_	_
7-22	1034-1044	primordial	event[39]|event[41]	new[39]|new[41]	coref	8-1[43_41]
7-23	1045-1053	follicle	event[39]|object|event[41]	new[39]|giv|new[41]	coref	14-31
7-24	1054-1064	activation	event[39]|event[41]	new[39]|new[41]	_	_
7-25	1065-1069	into	event[39]	new[39]	_	_
7-26	1070-1075	early	event[39]|animal[42]	new[39]|giv[42]	coref	11-4[69_42]
7-27	1076-1083	growing	event[39]|animal[42]	new[39]|giv[42]	_	_
7-28	1084-1093	follicles	event[39]|animal[42]	new[39]|giv[42]	_	_
7-29	1094-1095	.	_	_	_	_

#Text=This activation , starting during fetal life , is finely controlled though maintaining a balance between inhibitory and stimulatory factors .
8-1	1096-1100	This	event[43]	giv[43]	coref	9-21[54_43]
8-2	1101-1111	activation	event[43]	giv[43]	_	_
8-3	1112-1113	,	event[43]	giv[43]	_	_
8-4	1114-1122	starting	event[43]	giv[43]	_	_
8-5	1123-1129	during	event[43]	giv[43]	_	_
8-6	1130-1135	fetal	event[43]|abstract[44]	giv[43]|giv[44]	coref	17-2[144_44]
8-7	1136-1140	life	event[43]|abstract[44]	giv[43]|giv[44]	_	_
8-8	1141-1142	,	_	_	_	_
8-9	1143-1145	is	_	_	_	_
8-10	1146-1152	finely	_	_	_	_
8-11	1153-1163	controlled	_	_	_	_
8-12	1164-1170	though	_	_	_	_
8-13	1171-1182	maintaining	_	_	_	_
8-14	1183-1184	a	abstract[45]	new[45]	coref	20-13[174_45]
8-15	1185-1192	balance	abstract[45]	new[45]	_	_
8-16	1193-1200	between	abstract[45]	new[45]	_	_
8-17	1201-1211	inhibitory	abstract[45]|abstract[46]	new[45]|new[46]	coref	10-1[55_46]
8-18	1212-1215	and	abstract[45]|abstract[46]	new[45]|new[46]	_	_
8-19	1216-1227	stimulatory	abstract[45]|abstract[46]	new[45]|new[46]	_	_
8-20	1228-1235	factors	abstract[45]|abstract[46]	new[45]|new[46]	_	_
8-21	1236-1237	.	_	_	_	_

#Text=In vitro experiments and genetically modified mouse or sheep models have enabled the decoding of the molecular mechanisms that control follicular activation .
9-1	1238-1240	In	_	_	_	_
9-2	1241-1246	vitro	organization|event[48]	new|new[48]	_	_
9-3	1247-1258	experiments	event[48]	new[48]	_	_
9-4	1259-1262	and	_	_	_	_
9-5	1263-1274	genetically	abstract[51]	new[51]	coref	13-4[99_51]
9-6	1275-1283	modified	abstract[51]	new[51]	_	_
9-7	1284-1289	mouse	animal|abstract[51]	new|new[51]	coref	13-6
9-8	1290-1292	or	abstract[51]	new[51]	_	_
9-9	1293-1298	sheep	animal|abstract[51]	new|new[51]	_	_
9-10	1299-1305	models	abstract[51]	new[51]	_	_
9-11	1306-1310	have	_	_	_	_
9-12	1311-1318	enabled	_	_	_	_
9-13	1319-1322	the	event[52]	new[52]	_	_
9-14	1323-1331	decoding	event[52]	new[52]	_	_
9-15	1332-1334	of	event[52]	new[52]	_	_
9-16	1335-1338	the	event[52]|abstract[53]	new[52]|new[53]	coref	17-14[147_53]
9-17	1339-1348	molecular	event[52]|abstract[53]	new[52]|new[53]	_	_
9-18	1349-1359	mechanisms	event[52]|abstract[53]	new[52]|new[53]	_	_
9-19	1360-1364	that	event[52]|abstract[53]	new[52]|new[53]	_	_
9-20	1365-1372	control	event[52]|abstract[53]|abstract	new[52]|new[53]|new	coref|none	13-30[108_0]|9-20[0_108]
9-21	1373-1383	follicular	event[52]|abstract[53]|event[54]	new[52]|new[53]|giv[54]	coref	12-20[97_54]
9-22	1384-1394	activation	event[52]|abstract[53]|event[54]	new[52]|new[53]|giv[54]	_	_
9-23	1395-1396	.	_	_	_	_

#Text=Numerous factors , such as growth factors , hormones , transcription factors , or cytokines , produced by oocytes and/or granulosa cells , can act in an autocrine , paracrine , or endocrine manner .
10-1	1397-1405	Numerous	abstract[55]	giv[55]	coref	10-6[57_55]
10-2	1406-1413	factors	abstract[55]	giv[55]	_	_
10-3	1414-1415	,	abstract[55]	giv[55]	_	_
10-4	1416-1420	such	abstract[55]	giv[55]	_	_
10-5	1421-1423	as	abstract[55]	giv[55]	_	_
10-6	1424-1430	growth	abstract[55]|abstract|abstract[57]|abstract[58]	giv[55]|new|giv[57]|giv[58]	coref|coref	10-6[58_57]|10-11[61_58]
10-7	1431-1438	factors	abstract[55]|abstract[57]|abstract[58]	giv[55]|giv[57]|giv[58]	_	_
10-8	1439-1440	,	abstract[55]|abstract[58]	giv[55]|giv[58]	_	_
10-9	1441-1449	hormones	abstract[55]|abstract[58]|substance	giv[55]|giv[58]|new	_	_
10-10	1450-1451	,	abstract[55]|abstract[58]	giv[55]|giv[58]	_	_
10-11	1452-1465	transcription	abstract[55]|abstract[58]|abstract|abstract[61]	giv[55]|giv[58]|new|giv[61]	coref|coref	16-2|20-19[177_61]
10-12	1466-1473	factors	abstract[55]|abstract[58]|abstract[61]	giv[55]|giv[58]|giv[61]	_	_
10-13	1474-1475	,	abstract[55]|abstract[58]	giv[55]|giv[58]	_	_
10-14	1476-1478	or	abstract[55]|abstract[58]	giv[55]|giv[58]	_	_
10-15	1479-1488	cytokines	abstract[55]|abstract[58]|abstract	giv[55]|giv[58]|new	_	_
10-16	1489-1490	,	abstract[55]	giv[55]	_	_
10-17	1491-1499	produced	abstract[55]	giv[55]	_	_
10-18	1500-1502	by	abstract[55]	giv[55]	_	_
10-19	1503-1510	oocytes	abstract[55]|plant|plant[64]	giv[55]|giv|giv[64]	coref|coref	10-19[64_0]|12-17[0_64]
10-20	1511-1517	and/or	abstract[55]|plant[64]	giv[55]|giv[64]	_	_
10-21	1518-1527	granulosa	abstract[55]|plant[64]|animal|object[66]	giv[55]|giv[64]|new|new[66]	_	_
10-22	1528-1533	cells	abstract[55]|plant[64]|object[66]	giv[55]|giv[64]|new[66]	_	_
10-23	1534-1535	,	_	_	_	_
10-24	1536-1539	can	_	_	_	_
10-25	1540-1543	act	_	_	_	_
10-26	1544-1546	in	_	_	_	_
10-27	1547-1549	an	abstract[67]	new[67]	coref	20-2[169_67]
10-28	1550-1559	autocrine	abstract[67]	new[67]	_	_
10-29	1560-1561	,	abstract[67]	new[67]	_	_
10-30	1562-1571	paracrine	abstract[67]	new[67]	_	_
10-31	1572-1573	,	abstract[67]	new[67]	_	_
10-32	1574-1576	or	abstract[67]	new[67]	_	_
10-33	1577-1586	endocrine	abstract[67]	new[67]	_	_
10-34	1587-1593	manner	abstract[67]	new[67]	_	_
10-35	1594-1595	.	_	_	_	_

#Text=The quiescence of primordial follicles is maintained by several molecules including phosphatase and tensin homolog deleted on chromosome 10 ( Pten ) , tuberous sclerosis complexes 1 – 2 ( Tsc1 – Tsc2 ) complex , Forkhead box protein O3A ( Foxo3A ) , p27 , anti-Müllerian hormone ( AMH ) , and Forkhead box L2 ( FoxL2 ) .
11-1	1596-1599	The	abstract[68]	new[68]	_	_
11-2	1600-1610	quiescence	abstract[68]	new[68]	_	_
11-3	1611-1613	of	abstract[68]	new[68]	_	_
11-4	1614-1624	primordial	abstract[68]|animal[69]	new[68]|giv[69]	coref	13-37[112_69]
11-5	1625-1634	follicles	abstract[68]|animal[69]	new[68]|giv[69]	_	_
11-6	1635-1637	is	_	_	_	_
11-7	1638-1648	maintained	_	_	_	_
11-8	1649-1651	by	_	_	_	_
11-9	1652-1659	several	abstract[70]	new[70]	coref	22-14[191_70]
11-10	1660-1669	molecules	abstract[70]	new[70]	_	_
11-11	1670-1679	including	abstract[70]	new[70]	_	_
11-12	1680-1691	phosphatase	abstract[70]|abstract	new[70]|new	_	_
11-13	1692-1695	and	abstract[70]	new[70]	_	_
11-14	1696-1702	tensin	abstract[70]|person|abstract[73]	new[70]|new|new[73]	_	_
11-15	1703-1710	homolog	abstract[70]|abstract[73]	new[70]|new[73]	_	_
11-16	1711-1718	deleted	abstract[70]|abstract[73]	new[70]|new[73]	_	_
11-17	1719-1721	on	abstract[70]|abstract[73]	new[70]|new[73]	_	_
11-18	1722-1732	chromosome	abstract[70]|abstract[73]|object[74]	new[70]|new[73]|new[74]	_	_
11-19	1733-1735	10	abstract[70]|abstract[73]|object[74]	new[70]|new[73]|new[74]	_	_
11-20	1736-1737	(	abstract[70]	new[70]	_	_
11-21	1738-1742	Pten	abstract[70]	new[70]	_	_
11-22	1743-1744	)	abstract[70]	new[70]	_	_
11-23	1745-1746	,	abstract[70]	new[70]	_	_
11-24	1747-1755	tuberous	abstract[70]|abstract[76]	new[70]|new[76]	appos	11-31[0_76]
11-25	1756-1765	sclerosis	abstract[70]|animal|abstract[76]	new[70]|new|new[76]	_	_
11-26	1766-1775	complexes	abstract[70]|abstract[76]	new[70]|new[76]	_	_
11-27	1776-1777	1	abstract[70]|abstract[76]	new[70]|new[76]	_	_
11-28	1778-1779	–	abstract[70]|abstract[76]	new[70]|new[76]	_	_
11-29	1780-1781	2	abstract[70]|abstract[76]	new[70]|new[76]	_	_
11-30	1782-1783	(	abstract[70]	new[70]	_	_
11-31	1784-1788	Tsc1	abstract[70]|abstract	new[70]|giv	appos	11-33
11-32	1789-1790	–	abstract[70]	new[70]	_	_
11-33	1791-1795	Tsc2	abstract[70]|abstract	new[70]|giv	_	_
11-34	1796-1797	)	abstract[70]	new[70]	_	_
11-35	1798-1805	complex	abstract[70]|abstract	new[70]|new	_	_
11-36	1806-1807	,	abstract[70]	new[70]	_	_
11-37	1808-1816	Forkhead	abstract[70]|object|substance[82]	new[70]|new|new[82]	coref|coref	11-54|21-14[186_82]
11-38	1817-1820	box	abstract[70]|object|substance[82]	new[70]|new|new[82]	coref	11-54[88_0]
11-39	1821-1828	protein	abstract[70]|substance[82]	new[70]|new[82]	_	_
11-40	1829-1832	O3A	abstract[70]|substance[82]	new[70]|new[82]	_	_
11-41	1833-1834	(	abstract[70]	new[70]	_	_
11-42	1835-1841	Foxo3A	abstract[70]|abstract	new[70]|new	coref	16-1[136_0]
11-43	1842-1843	)	abstract[70]	new[70]	_	_
11-44	1844-1845	,	abstract[70]	new[70]	_	_
11-45	1846-1849	p27	abstract[70]|abstract	new[70]|new	_	_
11-46	1850-1851	,	abstract[70]	new[70]	_	_
11-47	1852-1866	anti-Müllerian	abstract[70]|substance[85]	new[70]|new[85]	_	_
11-48	1867-1874	hormone	abstract[70]|substance[85]	new[70]|new[85]	_	_
11-49	1875-1876	(	abstract[70]	new[70]	_	_
11-50	1877-1880	AMH	abstract[70]|abstract	new[70]|new	_	_
11-51	1881-1882	)	abstract[70]	new[70]	_	_
11-52	1883-1884	,	abstract[70]	new[70]	_	_
11-53	1885-1888	and	abstract[70]	new[70]	_	_
11-54	1889-1897	Forkhead	abstract[70]|object|object[88]	new[70]|giv|giv[88]	_	_
11-55	1898-1901	box	abstract[70]|object[88]	new[70]|giv[88]	_	_
11-56	1902-1904	L2	abstract[70]|object[88]	new[70]|giv[88]	_	_
11-57	1905-1906	(	_	_	_	_
11-58	1907-1912	FoxL2	abstract	new	_	_
11-59	1913-1914	)	_	_	_	_
11-60	1915-1916	.	_	_	_	_

#Text=Many studies have highlighted the crucial roles of the phosphatidyl-inositol-3-kinase ( PI3K ) signaling pathway in oocytes in controlling follicular activation .
12-1	1917-1921	Many	abstract[90]	new[90]	coref	18-1[151_90]
12-2	1922-1929	studies	abstract[90]	new[90]	_	_
12-3	1930-1934	have	_	_	_	_
12-4	1935-1946	highlighted	_	_	_	_
12-5	1947-1950	the	abstract[91]	new[91]	_	_
12-6	1951-1958	crucial	abstract[91]	new[91]	_	_
12-7	1959-1964	roles	abstract[91]	new[91]	_	_
12-8	1965-1967	of	abstract[91]	new[91]	_	_
12-9	1968-1971	the	abstract[91]|abstract[95]	new[91]|new[95]	ana	13-9[0_95]
12-10	1972-2002	phosphatidyl-inositol-3-kinase	abstract[91]|abstract|abstract[95]	new[91]|new|new[95]	appos	12-12
12-11	2003-2004	(	abstract[91]|abstract[95]	new[91]|new[95]	_	_
12-12	2005-2009	PI3K	abstract[91]|abstract|abstract[95]	new[91]|giv|new[95]	coref	13-14
12-13	2010-2011	)	abstract[91]|abstract[95]	new[91]|new[95]	_	_
12-14	2012-2021	signaling	abstract[91]|abstract|abstract[95]	new[91]|new|new[95]	coref	13-25
12-15	2022-2029	pathway	abstract[91]|abstract[95]	new[91]|new[95]	_	_
12-16	2030-2032	in	abstract[91]|abstract[95]	new[91]|new[95]	_	_
12-17	2033-2040	oocytes	abstract[91]|abstract[95]|plant	new[91]|new[95]|giv	coref	14-27
12-18	2041-2043	in	_	_	_	_
12-19	2044-2055	controlling	_	_	_	_
12-20	2056-2066	follicular	event[97]	giv[97]	coref	13-35[111_97]
12-21	2067-2077	activation	event[97]	giv[97]	_	_
12-22	2078-2079	.	_	_	_	_

#Text=Indeed , in genetically modified mouse models , it was observed that the PI3K – Akt – mammalian target of rapamycin ( mTOR ) signaling pathway is crucial for the control of survival and activation of primordial follicles .
13-1	2080-2086	Indeed	_	_	_	_
13-2	2087-2088	,	_	_	_	_
13-3	2089-2091	in	_	_	_	_
13-4	2092-2103	genetically	abstract[99]	giv[99]	coref	15-2[125_99]
13-5	2104-2112	modified	abstract[99]	giv[99]	_	_
13-6	2113-2118	mouse	animal|abstract[99]	giv|giv[99]	_	_
13-7	2119-2125	models	abstract[99]	giv[99]	_	_
13-8	2126-2127	,	_	_	_	_
13-9	2128-2130	it	abstract	giv	coref	13-13[107_0]
13-10	2131-2134	was	_	_	_	_
13-11	2135-2143	observed	_	_	_	_
13-12	2144-2148	that	_	_	_	_
13-13	2149-2152	the	abstract[107]	giv[107]	coref	14-13[117_107]
13-14	2153-2157	PI3K	abstract|abstract[107]	giv|giv[107]	coref	16-19
13-15	2158-2159	–	abstract[107]	giv[107]	_	_
13-16	2160-2163	Akt	abstract|abstract[107]	new|giv[107]	_	_
13-17	2164-2165	–	abstract[107]	giv[107]	_	_
13-18	2166-2175	mammalian	abstract[103]|abstract[107]	new[103]|giv[107]	_	_
13-19	2176-2182	target	abstract[103]|abstract[107]	new[103]|giv[107]	_	_
13-20	2183-2185	of	abstract[103]|abstract[107]	new[103]|giv[107]	_	_
13-21	2186-2195	rapamycin	abstract[103]|substance|abstract[107]	new[103]|new|giv[107]	_	_
13-22	2196-2197	(	abstract[107]	giv[107]	_	_
13-23	2198-2202	mTOR	abstract|abstract[107]	new|giv[107]	coref	15-5
13-24	2203-2204	)	abstract[107]	giv[107]	_	_
13-25	2205-2214	signaling	abstract|abstract[107]	giv|giv[107]	coref	14-14
13-26	2215-2222	pathway	abstract[107]	giv[107]	_	_
13-27	2223-2225	is	_	_	_	_
13-28	2226-2233	crucial	_	_	_	_
13-29	2234-2237	for	_	_	_	_
13-30	2238-2241	the	abstract[108]	new[108]	_	_
13-31	2242-2249	control	abstract[108]	new[108]	_	_
13-32	2250-2252	of	abstract[108]	new[108]	_	_
13-33	2253-2261	survival	abstract[108]|event|event[110]	new[108]|new|new[110]	coref	20-6[172_110]
13-34	2262-2265	and	abstract[108]|event[110]	new[108]|new[110]	_	_
13-35	2266-2276	activation	abstract[108]|event[110]|event[111]	new[108]|new[110]|giv[111]	coref	14-30[123_111]
13-36	2277-2279	of	abstract[108]|event[110]|event[111]	new[108]|new[110]|giv[111]	_	_
13-37	2280-2290	primordial	abstract[108]|event[110]|event[111]|animal[112]	new[108]|new[110]|giv[111]|giv[112]	coref	16-12[138_112]
13-38	2291-2300	follicles	abstract[108]|event[110]|event[111]|animal[112]	new[108]|new[110]|giv[111]|giv[112]	_	_
13-39	2301-2302	.	_	_	_	_

#Text=For example , Pten and Tsc1 – 2 are negative regulators of this signaling pathway and , in mice , the deletion of these genes from oocytes leads to primordial follicle activation and subsequent early follicular depletion .
14-1	2303-2306	For	_	_	_	_
14-2	2307-2314	example	_	_	_	_
14-3	2315-2316	,	_	_	_	_
14-4	2317-2321	Pten	abstract	new	_	_
14-5	2322-2325	and	_	_	_	_
14-6	2326-2330	Tsc1	substance[114]	new[114]	coref	14-10[115_114]
14-7	2331-2332	–	substance[114]	new[114]	_	_
14-8	2333-2334	2	substance[114]	new[114]	_	_
14-9	2335-2338	are	_	_	_	_
14-10	2339-2347	negative	substance[115]	giv[115]	_	_
14-11	2348-2358	regulators	substance[115]	giv[115]	_	_
14-12	2359-2361	of	substance[115]	giv[115]	_	_
14-13	2362-2366	this	substance[115]|abstract[117]	giv[115]|giv[117]	coref	16-18[141_117]
14-14	2367-2376	signaling	substance[115]|abstract|abstract[117]	giv[115]|giv|giv[117]	coref	16-20
14-15	2377-2384	pathway	substance[115]|abstract[117]	giv[115]|giv[117]	_	_
14-16	2385-2388	and	_	_	_	_
14-17	2389-2390	,	_	_	_	_
14-18	2391-2393	in	_	_	_	_
14-19	2394-2398	mice	animal	new	_	_
14-20	2399-2400	,	_	_	_	_
14-21	2401-2404	the	event[119]	new[119]	_	_
14-22	2405-2413	deletion	event[119]	new[119]	_	_
14-23	2414-2416	of	event[119]	new[119]	_	_
14-24	2417-2422	these	event[119]|abstract[120]	new[119]|new[120]	_	_
14-25	2423-2428	genes	event[119]|abstract[120]	new[119]|new[120]	_	_
14-26	2429-2433	from	event[119]	new[119]	_	_
14-27	2434-2441	oocytes	event[119]|plant	new[119]|giv	coref	16-9[137_0]
14-28	2442-2447	leads	_	_	_	_
14-29	2448-2450	to	_	_	_	_
14-30	2451-2461	primordial	event[123]	giv[123]	coref	15-22[133_123]
14-31	2462-2470	follicle	object|event[123]	giv|giv[123]	coref	15-23
14-32	2471-2481	activation	event[123]	giv[123]	_	_
14-33	2482-2485	and	_	_	_	_
14-34	2486-2496	subsequent	event[124]	new[124]	_	_
14-35	2497-2502	early	event[124]	new[124]	_	_
14-36	2503-2513	follicular	event[124]	new[124]	_	_
14-37	2514-2523	depletion	event[124]	new[124]	_	_
14-38	2524-2525	.	_	_	_	_

#Text=In these models , mTOR activity is accelerated within the oocyte , highlighting the critical role of this serine/threonine kinase in primordial follicle activation .
15-1	2526-2528	In	_	_	_	_
15-2	2529-2534	these	abstract[125]	giv[125]	_	_
15-3	2535-2541	models	abstract[125]	giv[125]	_	_
15-4	2542-2543	,	_	_	_	_
15-5	2544-2548	mTOR	abstract|abstract[127]	giv|new[127]	_	_
15-6	2549-2557	activity	abstract[127]	new[127]	_	_
15-7	2558-2560	is	_	_	_	_
15-8	2561-2572	accelerated	_	_	_	_
15-9	2573-2579	within	_	_	_	_
15-10	2580-2583	the	object[128]	new[128]	coref	19-11[0_128]
15-11	2584-2590	oocyte	object[128]	new[128]	_	_
15-12	2591-2592	,	_	_	_	_
15-13	2593-2605	highlighting	_	_	_	_
15-14	2606-2609	the	abstract[129]	new[129]	coref	21-22[188_129]
15-15	2610-2618	critical	abstract[129]	new[129]	_	_
15-16	2619-2623	role	abstract[129]	new[129]	_	_
15-17	2624-2626	of	abstract[129]	new[129]	_	_
15-18	2627-2631	this	abstract[129]|abstract[131]	new[129]|new[131]	_	_
15-19	2632-2648	serine/threonine	abstract[129]|abstract|abstract[131]	new[129]|new|new[131]	_	_
15-20	2649-2655	kinase	abstract[129]|abstract[131]	new[129]|new[131]	_	_
15-21	2656-2658	in	abstract[129]	new[129]	_	_
15-22	2659-2669	primordial	abstract[129]|event[133]	new[129]|giv[133]	coref	16-31[143_133]
15-23	2670-2678	follicle	abstract[129]|object|event[133]	new[129]|giv|giv[133]	coref	20-7
15-24	2679-2689	activation	abstract[129]|event[133]	new[129]|giv[133]	_	_
15-25	2690-2691	.	_	_	_	_

#Text=The transcription factor FoxO3A , mainly expressed in the oocytes of resting follicles , acts downstream of the PI3K signaling pathway and appears to be the main actor involved in follicular activation .
16-1	2692-2695	The	abstract[135]|abstract[136]	new[135]|giv[136]	_	_
16-2	2696-2709	transcription	abstract|abstract[135]|abstract[136]	giv|new[135]|giv[136]	_	_
16-3	2710-2716	factor	abstract[135]|abstract[136]	new[135]|giv[136]	_	_
16-4	2717-2723	FoxO3A	abstract[135]|abstract[136]	new[135]|giv[136]	_	_
16-5	2724-2725	,	abstract[135]|abstract[136]	new[135]|giv[136]	_	_
16-6	2726-2732	mainly	abstract[135]|abstract[136]	new[135]|giv[136]	_	_
16-7	2733-2742	expressed	abstract[135]|abstract[136]	new[135]|giv[136]	_	_
16-8	2743-2745	in	abstract[135]|abstract[136]	new[135]|giv[136]	_	_
16-9	2746-2749	the	abstract[135]|abstract[136]|plant[137]	new[135]|giv[136]|giv[137]	_	_
16-10	2750-2757	oocytes	abstract[135]|abstract[136]|plant[137]	new[135]|giv[136]|giv[137]	_	_
16-11	2758-2760	of	abstract[135]|abstract[136]|plant[137]	new[135]|giv[136]|giv[137]	_	_
16-12	2761-2768	resting	abstract[135]|abstract[136]|plant[137]|animal[138]	new[135]|giv[136]|giv[137]|giv[138]	coref	17-9[146_138]
16-13	2769-2778	follicles	abstract[135]|abstract[136]|plant[137]|animal[138]	new[135]|giv[136]|giv[137]|giv[138]	_	_
16-14	2779-2780	,	_	_	_	_
16-15	2781-2785	acts	_	_	_	_
16-16	2786-2796	downstream	_	_	_	_
16-17	2797-2799	of	_	_	_	_
16-18	2800-2803	the	abstract[141]	giv[141]	_	_
16-19	2804-2808	PI3K	abstract|abstract[141]	giv|giv[141]	_	_
16-20	2809-2818	signaling	abstract|abstract[141]	giv|giv[141]	coref	17-17[149_0]
16-21	2819-2826	pathway	abstract[141]	giv[141]	_	_
16-22	2827-2830	and	_	_	_	_
16-23	2831-2838	appears	_	_	_	_
16-24	2839-2841	to	_	_	_	_
16-25	2842-2844	be	_	_	_	_
16-26	2845-2848	the	abstract[142]	new[142]	_	_
16-27	2849-2853	main	abstract[142]	new[142]	_	_
16-28	2854-2859	actor	abstract[142]	new[142]	_	_
16-29	2860-2868	involved	abstract[142]	new[142]	_	_
16-30	2869-2871	in	abstract[142]	new[142]	_	_
16-31	2872-2882	follicular	abstract[142]|event[143]	new[142]|giv[143]	coref	22-9[190_143]
16-32	2883-2893	activation	abstract[142]|event[143]	new[142]|giv[143]	_	_
16-33	2894-2895	.	_	_	_	_

#Text=At the same time , the survival of primordial follicles is maintained by other mechanisms involving PDK1 signaling , rpS6 .
17-1	2896-2898	At	_	_	_	_
17-2	2899-2902	the	abstract[144]	giv[144]	_	_
17-3	2903-2907	same	abstract[144]	giv[144]	_	_
17-4	2908-2912	time	abstract[144]	giv[144]	_	_
17-5	2913-2914	,	_	_	_	_
17-6	2915-2918	the	event[145]	new[145]	coref	20-6[171_145]
17-7	2919-2927	survival	event[145]	new[145]	_	_
17-8	2928-2930	of	event[145]	new[145]	_	_
17-9	2931-2941	primordial	event[145]|animal[146]	new[145]|giv[146]	coref	18-19[157_146]
17-10	2942-2951	follicles	event[145]|animal[146]	new[145]|giv[146]	_	_
17-11	2952-2954	is	_	_	_	_
17-12	2955-2965	maintained	_	_	_	_
17-13	2966-2968	by	_	_	_	_
17-14	2969-2974	other	abstract[147]	giv[147]	coref	23-4[196_147]
17-15	2975-2985	mechanisms	abstract[147]	giv[147]	_	_
17-16	2986-2995	involving	abstract[147]	giv[147]	_	_
17-17	2996-3000	PDK1	abstract[147]|abstract|abstract[149]	giv[147]|new|giv[149]	appos	17-20[0_149]
17-18	3001-3010	signaling	abstract[147]|abstract[149]	giv[147]|giv[149]	_	_
17-19	3011-3012	,	_	_	_	_
17-20	3013-3017	rpS6	abstract	giv	_	_
17-21	3018-3019	.	_	_	_	_

#Text=Several studies have suggested the involvement of the autophagy process in the regulation of the ovarian reserve of primordial follicles .
18-1	3020-3027	Several	abstract[151]	giv[151]	_	_
18-2	3028-3035	studies	abstract[151]	giv[151]	_	_
18-3	3036-3040	have	_	_	_	_
18-4	3041-3050	suggested	_	_	_	_
18-5	3051-3054	the	abstract[152]	new[152]	_	_
18-6	3055-3066	involvement	abstract[152]	new[152]	_	_
18-7	3067-3069	of	abstract[152]	new[152]	_	_
18-8	3070-3073	the	abstract[152]|abstract[154]	new[152]|giv[154]	coref	22-31[193_154]
18-9	3074-3083	autophagy	abstract[152]|abstract|abstract[154]	new[152]|new|giv[154]	coref	19-4
18-10	3084-3091	process	abstract[152]|abstract[154]	new[152]|giv[154]	_	_
18-11	3092-3094	in	abstract[152]	new[152]	_	_
18-12	3095-3098	the	abstract[152]|abstract[155]	new[152]|giv[155]	_	_
18-13	3099-3109	regulation	abstract[152]|abstract[155]	new[152]|giv[155]	_	_
18-14	3110-3112	of	abstract[152]|abstract[155]	new[152]|giv[155]	_	_
18-15	3113-3116	the	abstract[152]|abstract[155]|place[156]	new[152]|giv[155]|giv[156]	coref	23-14[198_156]
18-16	3117-3124	ovarian	abstract[152]|abstract[155]|place[156]	new[152]|giv[155]|giv[156]	_	_
18-17	3125-3132	reserve	abstract[152]|abstract[155]|place[156]	new[152]|giv[155]|giv[156]	_	_
18-18	3133-3135	of	abstract[152]|abstract[155]|place[156]	new[152]|giv[155]|giv[156]	_	_
18-19	3136-3146	primordial	abstract[152]|abstract[155]|place[156]|animal[157]	new[152]|giv[155]|giv[156]|giv[157]	coref	19-35[168_157]
18-20	3147-3156	follicles	abstract[152]|abstract[155]|place[156]|animal[157]	new[152]|giv[155]|giv[156]|giv[157]	_	_
18-21	3157-3158	.	_	_	_	_

#Text=For example , autophagy is implicated in maintaining the primordial oocyte pool in murine newborns , and the induction of autophagy at birth seems to be a crucial step to preserve the stock of primordial follicles .
19-1	3159-3162	For	_	_	_	_
19-2	3163-3170	example	_	_	_	_
19-3	3171-3172	,	_	_	_	_
19-4	3173-3182	autophagy	abstract	giv	coref	19-21
19-5	3183-3185	is	_	_	_	_
19-6	3186-3196	implicated	_	_	_	_
19-7	3197-3199	in	_	_	_	_
19-8	3200-3211	maintaining	_	_	_	_
19-9	3212-3215	the	place[160]	giv[160]	_	_
19-10	3216-3226	primordial	place[160]	giv[160]	_	_
19-11	3227-3233	oocyte	object|place[160]	giv|giv[160]	_	_
19-12	3234-3238	pool	place[160]	giv[160]	_	_
19-13	3239-3241	in	_	_	_	_
19-14	3242-3248	murine	animal|animal[162]	new|new[162]	_	_
19-15	3249-3257	newborns	animal[162]	new[162]	_	_
19-16	3258-3259	,	_	_	_	_
19-17	3260-3263	and	_	_	_	_
19-18	3264-3267	the	event[163]	new[163]	_	_
19-19	3268-3277	induction	event[163]	new[163]	_	_
19-20	3278-3280	of	event[163]	new[163]	_	_
19-21	3281-3290	autophagy	event[163]|abstract	new[163]|giv	_	_
19-22	3291-3293	at	event[163]	new[163]	_	_
19-23	3294-3299	birth	event[163]|event	new[163]|new	_	_
19-24	3300-3305	seems	_	_	_	_
19-25	3306-3308	to	_	_	_	_
19-26	3309-3311	be	_	_	_	_
19-27	3312-3313	a	abstract[166]	new[166]	_	_
19-28	3314-3321	crucial	abstract[166]	new[166]	_	_
19-29	3322-3326	step	abstract[166]	new[166]	_	_
19-30	3327-3329	to	abstract[166]	new[166]	_	_
19-31	3330-3338	preserve	abstract[166]	new[166]	_	_
19-32	3339-3342	the	abstract[166]|substance[167]	new[166]|new[167]	_	_
19-33	3343-3348	stock	abstract[166]|substance[167]	new[166]|new[167]	_	_
19-34	3349-3351	of	abstract[166]|substance[167]	new[166]|new[167]	_	_
19-35	3352-3362	primordial	abstract[166]|substance[167]|animal[168]	new[166]|new[167]|giv[168]	_	_
19-36	3363-3372	follicles	abstract[166]|substance[167]|animal[168]	new[166]|new[167]|giv[168]	_	_
19-37	3373-3374	.	_	_	_	_

#Text=In the same manner , primordial follicle survival or apoptosis results from a balance between the expression of survival ( antiapoptotic ) and proapoptotic factors .
20-1	3375-3377	In	_	_	_	_
20-2	3378-3381	the	abstract[169]	giv[169]	_	_
20-3	3382-3386	same	abstract[169]	giv[169]	_	_
20-4	3387-3393	manner	abstract[169]	giv[169]	_	_
20-5	3394-3395	,	_	_	_	_
20-6	3396-3406	primordial	event[171]|event[172]	giv[171]|giv[172]	coref	20-19[0_171]
20-7	3407-3415	follicle	object|event[171]|event[172]	giv|giv[171]|giv[172]	_	_
20-8	3416-3424	survival	event[171]|event[172]	giv[171]|giv[172]	_	_
20-9	3425-3427	or	event[172]	giv[172]	_	_
20-10	3428-3437	apoptosis	event[172]|abstract	giv[172]|new	_	_
20-11	3438-3445	results	_	_	_	_
20-12	3446-3450	from	_	_	_	_
20-13	3451-3452	a	abstract[174]	giv[174]	_	_
20-14	3453-3460	balance	abstract[174]	giv[174]	_	_
20-15	3461-3468	between	abstract[174]	giv[174]	_	_
20-16	3469-3472	the	abstract[174]|abstract[175]	giv[174]|new[175]	_	_
20-17	3473-3483	expression	abstract[174]|abstract[175]	giv[174]|new[175]	_	_
20-18	3484-3486	of	abstract[174]|abstract[175]	giv[174]|new[175]	_	_
20-19	3487-3495	survival	abstract[174]|abstract[175]|event|abstract[177]	giv[174]|new[175]|giv|giv[177]	coref	21-2[178_177]
20-20	3496-3497	(	abstract[174]|abstract[175]|abstract[177]	giv[174]|new[175]|giv[177]	_	_
20-21	3498-3511	antiapoptotic	abstract[174]|abstract[175]|abstract[177]	giv[174]|new[175]|giv[177]	_	_
20-22	3512-3513	)	abstract[174]|abstract[175]|abstract[177]	giv[174]|new[175]|giv[177]	_	_
20-23	3514-3517	and	abstract[174]|abstract[175]|abstract[177]	giv[174]|new[175]|giv[177]	_	_
20-24	3518-3530	proapoptotic	abstract[174]|abstract[175]|abstract[177]	giv[174]|new[175]|giv[177]	_	_
20-25	3531-3538	factors	abstract[174]|abstract[175]|abstract[177]	giv[174]|new[175]|giv[177]	_	_
20-26	3539-3540	.	_	_	_	_

#Text=Among these factors , the proteins B-cell lymphoma 2 ( Bcl-2 ) and Bcl-2-associated X protein ( BAX ) likely play a critical role .
21-1	3541-3546	Among	_	_	_	_
21-2	3547-3552	these	abstract[178]	giv[178]	_	_
21-3	3553-3560	factors	abstract[178]	giv[178]	_	_
21-4	3561-3562	,	_	_	_	_
21-5	3563-3566	the	substance[179]	new[179]	appos	21-7[181_179]
21-6	3567-3575	proteins	substance[179]	new[179]	_	_
21-7	3576-3582	B-cell	abstract|substance[181]	new|giv[181]	appos	21-9[0_181]
21-8	3583-3591	lymphoma	substance[181]	giv[181]	_	_
21-9	3592-3593	2	substance	giv	_	_
21-10	3594-3595	(	_	_	_	_
21-11	3596-3601	Bcl-2	abstract	new	_	_
21-12	3602-3603	)	_	_	_	_
21-13	3604-3607	and	_	_	_	_
21-14	3608-3624	Bcl-2-associated	object|substance[186]	new|giv[186]	_	_
21-15	3625-3626	X	person|substance[186]	new|giv[186]	_	_
21-16	3627-3634	protein	substance[186]	giv[186]	_	_
21-17	3635-3636	(	_	_	_	_
21-18	3637-3640	BAX	abstract	new	_	_
21-19	3641-3642	)	_	_	_	_
21-20	3643-3649	likely	_	_	_	_
21-21	3650-3654	play	_	_	_	_
21-22	3655-3656	a	abstract[188]	giv[188]	_	_
21-23	3657-3665	critical	abstract[188]	giv[188]	_	_
21-24	3666-3670	role	abstract[188]	giv[188]	_	_
21-25	3671-3672	.	_	_	_	_

#Text=Thus , a synergistic and coordinated suppression of follicular activation , provided by multiple inhibitory and activator molecules , is necessary to preserve the primordial follicular stockpile in association with the process maintaining dormancy .
22-1	3673-3677	Thus	_	_	_	_
22-2	3678-3679	,	_	_	_	_
22-3	3680-3681	a	event[189]	new[189]	_	_
22-4	3682-3693	synergistic	event[189]	new[189]	_	_
22-5	3694-3697	and	event[189]	new[189]	_	_
22-6	3698-3709	coordinated	event[189]	new[189]	_	_
22-7	3710-3721	suppression	event[189]	new[189]	_	_
22-8	3722-3724	of	event[189]	new[189]	_	_
22-9	3725-3735	follicular	event[189]|event[190]	new[189]|giv[190]	_	_
22-10	3736-3746	activation	event[189]|event[190]	new[189]|giv[190]	_	_
22-11	3747-3748	,	event[189]	new[189]	_	_
22-12	3749-3757	provided	event[189]	new[189]	_	_
22-13	3758-3760	by	event[189]	new[189]	_	_
22-14	3761-3769	multiple	event[189]|abstract[191]	new[189]|giv[191]	_	_
22-15	3770-3780	inhibitory	event[189]|abstract[191]	new[189]|giv[191]	_	_
22-16	3781-3784	and	event[189]|abstract[191]	new[189]|giv[191]	_	_
22-17	3785-3794	activator	event[189]|abstract[191]	new[189]|giv[191]	_	_
22-18	3795-3804	molecules	event[189]|abstract[191]	new[189]|giv[191]	_	_
22-19	3805-3806	,	_	_	_	_
22-20	3807-3809	is	_	_	_	_
22-21	3810-3819	necessary	_	_	_	_
22-22	3820-3822	to	_	_	_	_
22-23	3823-3831	preserve	_	_	_	_
22-24	3832-3835	the	substance[192]	new[192]	_	_
22-25	3836-3846	primordial	substance[192]	new[192]	_	_
22-26	3847-3857	follicular	substance[192]	new[192]	_	_
22-27	3858-3867	stockpile	substance[192]	new[192]	_	_
22-28	3868-3870	in	_	_	_	_
22-29	3871-3882	association	_	_	_	_
22-30	3883-3887	with	_	_	_	_
22-31	3888-3891	the	abstract[193]	giv[193]	_	_
22-32	3892-3899	process	abstract[193]	giv[193]	_	_
22-33	3900-3911	maintaining	abstract[193]	giv[193]	_	_
22-34	3912-3920	dormancy	abstract[193]|abstract	giv[193]|new	_	_
22-35	3921-3922	.	_	_	_	_

#Text=Any disorder in these complex mechanisms can lead to a premature loss of the follicular reserve .
23-1	3923-3926	Any	abstract[195]	new[195]	_	_
23-2	3927-3935	disorder	abstract[195]	new[195]	_	_
23-3	3936-3938	in	abstract[195]	new[195]	_	_
23-4	3939-3944	these	abstract[195]|abstract[196]	new[195]|giv[196]	_	_
23-5	3945-3952	complex	abstract[195]|abstract[196]	new[195]|giv[196]	_	_
23-6	3953-3963	mechanisms	abstract[195]|abstract[196]	new[195]|giv[196]	_	_
23-7	3964-3967	can	_	_	_	_
23-8	3968-3972	lead	_	_	_	_
23-9	3973-3975	to	_	_	_	_
23-10	3976-3977	a	event[197]	new[197]	_	_
23-11	3978-3987	premature	event[197]	new[197]	_	_
23-12	3988-3992	loss	event[197]	new[197]	_	_
23-13	3993-3995	of	event[197]	new[197]	_	_
23-14	3996-3999	the	event[197]|place[198]	new[197]|giv[198]	_	_
23-15	4000-4010	follicular	event[197]|place[198]	new[197]|giv[198]	_	_
23-16	4011-4018	reserve	event[197]|place[198]	new[197]|giv[198]	_	_
23-17	4019-4020	.	_	_	_	_
